BIOSPAIN 2026: Full Schedule

16:45 CEST

Advancing Cell & Gene Therapies: Challenges, Innovation & Market Translation

Tuesday September 29, 2026 16:45 - 17:30 CEST

Cell and gene therapies (CGT) have revolutionised the treatment of many conditions and they continue to attract significant levels of investment. Their development faces unique challenges, ranging from technical complexity, regulation, scaling production, and the requirement of innovative commercialization models. This roundtable will explore how CGT can be effectively translated into innovation that reaches the market, creates value, and improves people’s lives. A range of topics will be covered, with particular emphasis on some key challenges such as response durability, toxicity management, targeting of solid tumours, and the development of robust analytical workflows for functional characterisation, including approaches such as real-time cytotoxicity assays and multimodal cell profiling.

Speakers

James Cameron

Market Specialist for Cell & Molecular Research, Agilent NLD

James Cameron is a Market Specialist for BioPharma at Agilent Technologies, specializing in advancing cell and molecular research workflows, mRNA analysis, and critical quality attributes. He frequently acts as a moderator and subject matter expert for key industry discussions.
... Read More →

Gaël Roué

Junior Group Leader, Josep Carreras Leukaemia Research Institute

Me doctoré en 2002 en la Universidad de Caen (Francia) y trabajé entre 2002 y 2004 como postdoc asociado en el Instituto Pasteur (París, Francia). Posteriormente me trasladé al Hospital Clínic de Barcelona (España) para trabajar en la caracterización de terapias nuevas y traslacionales... Read More →

Miguel Angel Campanero

General Manager, Syngoy

Tuesday September 29, 2026 16:45 - 17:30 CEST
3 Nicolás Achúcarro room

Round table discussion

SPONSOR Agilent
Audience English language
Track Health

BIOSPAIN 2026

16:45 CEST

James Cameron

Gaël Roué

Miguel Angel Campanero

Get help with the event